Middle meningeal artery embolisation for chronic subdural haematomas Middle meningeal artery embolisation for chronic subdural haematomas Interventional procedures guidance Published: 14 December 2023 www.nice.org.uk/guidance/ipg779 Your responsibility This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement , authorise and monitor the introduction of new devices and procedures. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. 1 Recommendations 1.1 Middle meningeal artery embolisation for chronic subdural haematomas should be used only
Important information for young people: Protect yourself against infectious meningitis Skip to main contentSearchNorskMenuNIPH's website uses cookies. Read more about our use of cookies in our privacy policy.ClosePublicationsImportant information for young people: Protect yourself against infectious meningitisInformation note|Published 11.03.2024SharePrintAlerts about changesThe Norwegian Institute of Public Health recommends that young people aged 16-19 consider getting vaccinated against meningococcal disease (infectious meningitis). The information sheet provides information about the disease and available vaccine. It is intended for young people and their parents, but will also be useful for healthcare professionals offering vaccination.Download pdfBokmål - VIKTIG INFORMASJON TIL
Viral meningitis Skip to main contentSkip to searchAbout usHelpSubscribeAccess through your institutionLog inBMJ Best PracticeSearchSearchSelect languageViral meningitis MENULog in or subscribe to access all of BMJ Best PracticeLast reviewed:28 May 2023Last updated:22 Jun 2023SummaryViral meningitis must be distinguished from bacterial meningitis, which is associated with significant morbidity and mortality and requires urgent treatment including prompt antibiotics.Treat all patients with suspected meningitis in line with guidelines on bacterial meningitis until the diagnosis of bacterial meningitis is excluded or deemed unlikely. See Bacterial meningitis in adults and Bacterial meningitis in children.No specific treatment has been proven to be beneficial for viral meningitis.If testing identifies
Bacterial meningitis in adults Skip to main contentSkip to searchAbout usHelpSubscribeAccess through your institutionLog inBMJ Best PracticeSearchSearchSelect languageBacterial meningitis in adults MENULog in or subscribe to access all of BMJ Best PracticeLast reviewed:19 Jun 2023Last updated:18 Jul 2023SummaryBacterial meningitis represents a life-threatening inflammation of the meninges the specific organism is identified, target treatment accordingly.DefinitionBacterial meningitis is a serious inflammation of the meninges caused by various bacteria. Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae type b (Hib) are the predominant causative pathogens in adults. This topic covers non-meningococcal bacterial meningitis acquired by adults in the community; meningitis
Bacterial meningitis in children Skip to main contentSkip to searchAbout usHelpSubscribeAccess through your institutionLog inBMJ Best PracticeSearchSearchBacterial meningitis in children MENULog in or subscribe to access all of BMJ Best PracticeLast reviewed:10 Jan 2023Last updated:31 Jan 2023SummaryBacterial meningitis is a life-threatening inflammation of the meninges, which most commonly affects young children (<2 years of age) because of impaired immunity. It is a notifiable disease in the UK.If you suspect bacterial meningitis, obtain cerebrospinal fluid by performing a lumbar puncture (unless contraindicated); this is the most important investigation.Start empirical antimicrobial therapy promptly. When the specific organism is identified, target treatment
Meningococcal vaccines: WHO position paper on the use of multivalent meningococcal conjugate vaccines in countries of the African meningitis belt Weekly epidemiological recordRelevé épidémiologique hebdomadaire 12 JANUARY 2024, 99th YEAR / 12 JANVIER 2024, 99e ANNÉENos. 1/2, 2024, 99, 1–10http://www.who.int/wer2024, 99, 1–10Nos. 1/2Contents1 Meningococcal vaccines: WHO position paper on the use of multivalent meningococcal conjugate vaccines in countries of the African meningitis beltSommaire1 Note de synthèse: position de l’OMS sur l’utilisation des vaccins antiméningococciques conjugués multivalents dans les pays de la ceinture africaine de la méningite1Meningococcal vaccines: WHO position paper on the use of multivalent meningococcal conjugate vaccines in countries
Meningitis ' Emergency management in children Meningitis – Emergency management in children | Children's Health Queensland Skip to main content Skip to main navigation health.qld.gov.au Contact Us Search Menu Queensland Government Children's Health Queensland Search this website Search MenuClose * Home * Going to hospital Going to hospital Going to hospital * How to get here * Emergency management flowchart [PDF 473.18 KB] - 2 pagesKey points * Children with meningitis often present with nonspecific symptoms and not the classic triad of fever, headache and nuchal rigidity. * Bacterial meningitis is less common than viral meningitis but is a more serious disease that can result in neurological sequelae or even death. * Laboratory testing (blood and CSF) is required
A combination of tests is needed to diagnose a dangerous type of meningitis in children A combination of tests is needed to diagnose a dangerous type of meningitis in childrenA combination of tests is needed to diagnose a dangerous type of meningitis in children Skip to content * Accessibility options: * * Search articles Evidence * About Us * Browse content * Brain and Nerves * Birth Conditions Us * Browse content * Become a reviewer * Newsletter Sign Up * Contact us * Homepage * > * Alert * > * A combination of tests is needed to diagnose a dangerous type of meningitis in children A combination of tests is needed to diagnose a dangerous type of meningitis in childrenInfections 02.03.21 doi: 10.3310/alert_44418 View commentaries on this research This is a plain English summary
Pharmacometabolomics in TB meningitis-Understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluid. Poor penetration of many anti-tuberculosis (TB) antibiotics into the central nervous system (CNS) is thought to be a major driver of morbidity and mortality in TB meningitis (TBM). While the amount of a particular drug
Sensitization of meningeal afferents to locomotion-related meningeal deformations in a migraine model. Migraine headache is hypothesized to involve the activation and sensitization of trigeminal sensory afferents that innervate the cranial meninges. To better understand migraine pathophysiology and improve clinical translation, we used two-photon calcium imaging via a closed cranial window in awake mice to investigate changes in the responses of meningeal afferent fibers using a preclinical model of migraine involving cortical spreading depolarization (CSD). A single CSD episode caused a seconds-long wave of calcium activation that propagated across afferents and along the length of individual afferents. Surprisingly, unlike previous studies in anesthetized animals with exposed meninges
Predictors of Resolution of Meningitis Symptoms in Tuberculous Meningitis: A Clinical, Magnetic Resonance Imaging, and Biomarker Study. In tuberculous meningitis (TBM), the meningeal symptoms and their resolution after treatment may be dependent on clinical-radiological severity, cerebrospinal fluid (CSF), and proinflammatory cytokines, and these findings may be associated with outcome . There is a paucity of studies on the resolution of meningitis symptoms in TBM. We report on associations of clinical, magnetic resonance imaging (MRI), laboratory, and proinflammatory cytokines [tumor necrosis factor (TNF)-α and interleukin 6 (IL-6)] findings with the resolution of meningitis symptoms (RMS), and the impact of RMS duration on the outcome in TBM. Seventy-one patients with TBM were included
Bacterial meningitis and meningococcal disease CKS is only available in the UK | NICE CKS is only available in the UKThe NICE Clinical Knowledge Summaries (CKS) site is only available to users in the UK, Crown Dependencies and British Overseas Territories.CKS content is produced by Clarity Informatics Limited. It is available to users outside the UK via subscription from the Prodigy website.If
Prevalence, treatment, and factors associated with cryptococcal meningitis post introduction of integrase inhibitors antiretroviral based regimens among People Living with HIV in Tanzania. This study aimed to assess the prevalence of Cryptococcal Meningitis (CM), treatment practice, and the associated factors post-introduction of Tenofovir Lamivudine and Dolutegravir (TLD) regimen among People
Neurovascular Complications of Iatrogenic Fusarium solani Meningitis. A multinational outbreak of nosocomial fusarium meningitis occurred among immunocompetent patients who had undergone surgery with epidural anesthesia in Mexico. The pathogen involved had a high predilection for the brain stem and vertebrobasilar arterial system and was associated with high mortality from vessel injury
Neutrophil extracellular traps in CSF and serum of dogs with steroid-responsive meningitis-arteritis. In steroid-responsive meningitis-arteritis (SRMA), inflammatory dysregulation is driven by neutrophilic granulocytes resulting in purulent leptomeningitis. Neutrophils can generate neutrophil extracellular traps (NET). Uncontrolled NET-formation or impaired NET-clearance evidently cause tissue
Risk factors associated with meningitis outbreak in the Upper West Region of Ghana: A matched case-control study. The Northern part of Ghana lies within the African meningitis belt and has historically been experiencing seasonal meningitis outbreaks. Despite the continuous meningitis outbreak in the region, the risk factors contributing to the occurrence of these outbreaks have not been clearly identified. This study, therefore, sought to describe the clinical characteristics and possible risk factors associated with meningitis outbreaks in the Upper West Region (UWR). A 1:2 matched case-control study was conducted in May-December 2021 to retrospectively investigate possible risk factors for meningitis outbreak in the UWR of Ghana between January and December 2020. Cases were persons
Burden and bacterial etiology of neonatal meningitis at Hawassa University Comprehensive Specialized Hospital, Hawassa, Ethiopia. Meningitis poses a significant challenge to public health in low-income nations, such as Ethiopia, with a particular impact on newborns. The magnitude and etiologies of meningitis vary based on geographic location and age of patients. There is limited data regarding the magnitude and etiology of meningitis from Sidama Regional State, Ethiopia. This study aimed to determine the magnitude and bacterial profile of meningitis among newborns aged less than 90 days at Hawassa University Comprehensive Specialized Hospital (HUCSH). A retrospective cross-sectional study was conducted among newborns under 90 days who were suspected of meningitis at HUCSH from January 2019 to July
Meningeal contrast enhancement in multiple sclerosis: Assessment of field strength, acquisition delay, and clinical relevance. Leptomeningeal enhancement (LME) on post-contrast FLAIR is described as a potential biomarker of meningeal inflammation in multiple sclerosis (MS). Here we report an assessment of the impact of MRI field strength and acquisition timing on meningeal contrast enhancement contrast injection increased sensitivity for all forms of MCE. However, the lack of difference between groups for LME and its association with age calls into question its relevance as a biomarker of meningeal inflammation in MS.
Poor long-term outcomes despite improved hospital survival for patients with cryptococcal meningitis in rural, Northern Uganda. Cryptococcal meningitis (CM) remains a major cause of death among people living with HIV in rural sub-Saharan Africa. We previously reported that a CM diagnosis and treatment program (CM-DTP) improved hospital survival for CM patients in rural, northern Uganda